Global Methylenetetrahydrofolate Reductase Market Strategic Research Report

Scope of the Report

The global Methylenetetrahydrofolate Reductase market size is predicted to grow from US$ 398 million in 2025 to US$ 641 million in 2032; it is expected to grow at a CAGR of 7.1% from 2026 to 2032.

Methylenetetrahydrofolate Reductase (MTHFR) is an enzyme that plays a central role in one-carbon metabolism by catalyzing the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the active form of folate required for the remethylation of homocysteine to methionine, thereby supporting DNA synthesis, methylation processes, and cardiovascular health; in terms of supply chain, MTHFR is not traded as a bulk industrial chemical but exists within a life sciences and diagnostics ecosystem where upstream activities involve biochemical research, gene sequencing, and enzyme characterization (using reagents such as folates, cofactors like NADPH, and recombinant expression systems), midstream processes include the development and manufacturing of genetic testing kits, PCR reagents, and clinical diagnostic panels targeting MTHFR gene variants (e.g., C677T, A1298C), and downstream applications span clinical diagnostics laboratories, hospitals, nutrigenomics services, pharmaceutical research, and personalized medicine providers, with key stakeholders including biotech firms, diagnostic kit manufacturers, clinical labs, and healthcare institutions rather than traditional chemical manufacturers. In 2025, global Methylenetetrahydrofolate Reductase output was about 80 tons with 120 tons of capacity, average prices of USD 3,000–10,000 per kg, and gross margins around 37%.

Global key Methylenetetrahydrofolate Reductase players cover Merck (Germany), Thermo Fisher (USA), Bio-Techne (USA), RayBiotech (USA), Enzo Biochem (USA), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Methylenetetrahydrofolate Reductase market?

What factors are driving Methylenetetrahydrofolate Reductase market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Methylenetetrahydrofolate Reductase market opportunities vary by end market size?

How does Methylenetetrahydrofolate Reductase break out by Type, by Application?

This report presents a comprehensive overview of the global Methylenetetrahydrofolate Reductase market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• C677T Variant
• A1298C Variant

Segment by Enzyme Activity Level

• >70%
• 40–70%
• <40%

Segment by Application

• Clinical Diagnostic
• Genetic Testing
• Biopharmaceutical
• Academic Research

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Methylenetetrahydrofolate Reductase market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Clinical Diagnostic, Genetic Testing, Biopharmaceutical evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact